Advertisement
Advertisement
FLGT
Fulgent Genetics, Inc. Common Stock
15.96
USDSponsored
+0.16
+1.01%
May 13, 16:00 UTC -4
Closed
Pre-Market
15.96
0.00
0.00%
FLGT Earnings Reports
Positive Surprise Ratio
FLGT beat 29 of 39 last estimates.
74%
Next Report
Date of Next Report
Jul 30, 2026
Estimate for Q2 26 (Revenue/ EPS)
$93.60M
/-$0.44
Implied change from Q1 26 (Revenue/ EPS)
+31.58%
/+22.22%
Implied change from Q2 25 (Revenue/ EPS)
+14.42%
/-728.57%
Fulgent Genetics, Inc. Common Stock earnings per share and revenue
On May 01, 2026, FLGT reported earnings of -0.36 USD per share (EPS) for Q1 26, missing the estimate of -0.10 USD, resulting in a -236.13% surprise. Revenue reached 71.14 million, compared to an expected 69.46 million, with a 2.42% difference. The market reacted with a -6.98% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 5 analysts forecast an EPS of -0.44 USD, with revenue projected to reach 93.60 million USD, implying an increase of 22.22% EPS, and increase of 31.58% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Senseonics Holdings, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.69
Actual
-$0.71
Surprise
-2.79%
Evolent Health, Inc Class A Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.05
Actual
-$0.02
Surprise
+61.39%
Nyxoah SA Ordinary Shares
Report Date
May 12, 2026 For Q1 26
Estimate
-$0.50
Actual
-$0.36
Surprise
+27.56%
Insight Molecular Diagnostics Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.26
Actual
-$0.28
Surprise
-4.99%
Neuraxis, Inc.
Report Date
May 12, 2026 For Q1 26
Estimate
-$0.19
Actual
-$0.18
Surprise
+7.12%
Outset Medical, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.81
Actual
-$0.83
Surprise
-2.00%
Health Catalyst, Inc Common Stock
Report Date
May 11, 2026 For Q1 26
Estimate
$0.01
Actual
$0.02
Surprise
+14.29%
Hims & Hers Health, Inc.
Report Date
May 11, 2026 For Q1 26
Estimate
$0.04
Actual
-$0.18
Surprise
-507.24%
Doximity, Inc.
Report Date
May 13, 2026 For Q4 26
Estimate
$0.28
Actual
$0.26
Surprise
-9.97%
Heartbeam, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.14
Actual
-$0.12
Surprise
+14.77%
FAQ
What were Fulgent Genetics, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Fulgent Genetics, Inc. Common Stock reported EPS of -$0.36, missing estimates by -236.13%, and revenue of $71.14M, 2.42% above expectations.
How did the market react to Fulgent Genetics, Inc. Common Stock's Q1 2026 earnings?
The stock price moved down -6.98%, changed from $15.19 before the earnings release to $14.13 the day after.
When is Fulgent Genetics, Inc. Common Stock expected to report next?
The next earning report is scheduled for Jul 30, 2026.
What are the forecasts for Fulgent Genetics, Inc. Common Stock's next earnings report?
Based on 5
analysts, Fulgent Genetics, Inc. Common Stock is expected to report EPS of -$0.44 and revenue of $93.60M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement